Edwards Lifesciences (EW) Competitors

Henry Schein (NASDAQ:HSIC) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

Do institutionals and insiders have more ownership in HSIC or EW?

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.1% of Henry Schein shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has better valuation & earnings, HSIC or EW?

Edwards Lifesciences has lower revenue, but higher earnings than Henry Schein. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$12.67B	0.70	$390M	$3.20	22.69
Edwards Lifesciences	$5.52B	8.04	$4.17B	$7.00	10.81

Is HSIC or EW more profitable?

Edwards Lifesciences has a net margin of 75.48% compared to Henry Schein's net margin of 3.21%. Edwards Lifesciences' return on equity of 16.62% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.21%	14.87%	5.82%
Edwards Lifesciences	75.48%	16.62%	12.64%

Do analysts prefer HSIC or EW?

Henry Schein currently has a consensus price target of $78.36, indicating a potential upside of 7.91%. Edwards Lifesciences has a consensus price target of $81.37, indicating a potential upside of 7.52%. Given Henry Schein's higher probable upside, research analysts plainly believe Henry Schein is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	0 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.36
Edwards Lifesciences	1 Sell rating(s)	11 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.50

Which has more risk & volatility, HSIC or EW?

Henry Schein has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.

Does the media favor HSIC or EW?

In the previous week, Edwards Lifesciences had 28 more articles in the media than Henry Schein. MarketBeat recorded 36 mentions for Edwards Lifesciences and 8 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 0.86 beat Henry Schein's score of 0.67 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	19 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Edwards Lifesciences beats Henry Schein on 13 of the 17 factors compared between the two stocks.